BR9903282A - Compostos de nitrona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos - Google Patents
Compostos de nitrona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmosInfo
- Publication number
- BR9903282A BR9903282A BR9903282-1A BR9903282A BR9903282A BR 9903282 A BR9903282 A BR 9903282A BR 9903282 A BR9903282 A BR 9903282A BR 9903282 A BR9903282 A BR 9903282A
- Authority
- BR
- Brazil
- Prior art keywords
- same
- pharmaceutical compositions
- preparing
- compositions containing
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Patente de Invenção:<B>"COMPOSTOS DE NITRONA, UM PROCESSO PARA A PREPARAçãO DOS MESMOS E COMPOSIçõES FARMACêUTICAS QUE CONTêM OS MESMOS"<D>. Compostos de fórmula (I): em que: W representa um grupo arila, heteroarila ou heteroarilalquila, cada um daqueles grupos sendo opcionalmente substituído, R~ 1~ representa um grupo alquila, alquenila, alquinila, arila, cicloalquila, arilalquila ou cicloalquilalquila cada uma daqueles grupos sendo opcionalmente substituído. R~ 2~ é como definido no relatório descritivo, isómeros dos mesmos e também sais de adições dos mesmos com um ácido ou uma base farmaceuticamente aceitável. Medicamento.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9808116A FR2780404B1 (fr) | 1998-06-26 | 1998-06-26 | Nouveaux derives de nitrone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9903282A true BR9903282A (pt) | 2000-04-18 |
Family
ID=9527896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9903282-1A BR9903282A (pt) | 1998-06-26 | 1999-06-25 | Compostos de nitrona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos |
Country Status (17)
Country | Link |
---|---|
US (1) | US6034250A (pt) |
EP (1) | EP0967207B1 (pt) |
JP (1) | JP2000026428A (pt) |
CN (1) | CN1153766C (pt) |
AT (1) | ATE223904T1 (pt) |
AU (1) | AU747203B2 (pt) |
BR (1) | BR9903282A (pt) |
CA (1) | CA2274621C (pt) |
DE (1) | DE69902851T2 (pt) |
DK (1) | DK0967207T3 (pt) |
ES (1) | ES2183492T3 (pt) |
FR (1) | FR2780404B1 (pt) |
HU (1) | HUP9902199A1 (pt) |
NO (1) | NO312722B1 (pt) |
NZ (1) | NZ336460A (pt) |
PT (1) | PT967207E (pt) |
ZA (1) | ZA994201B (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6096899A (en) * | 1998-04-14 | 2000-08-01 | The Regents Of The University Of Michigan | Cylic imidazole compounds having relatively low hydrogen content and relatively high nitrogen content and polymers formed therefrom |
AU2002233643B2 (en) * | 2001-02-16 | 2007-07-26 | Asubio Pharma Co., Ltd. | Methods of treating diseases in association with decrease in the expression of AOP-1 gene or AOP-1 and remedies for the diseases |
WO2003010154A1 (en) * | 2001-07-26 | 2003-02-06 | Samsung Electronics Co. Ltd. | Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses |
EP2324830A1 (en) * | 2002-03-05 | 2011-05-25 | TransTech Pharma Inc. | Process for the preparation of a monocyclic azole derivative that inhibits the interaction of ligands with rage |
AU2003230770A1 (en) * | 2002-03-28 | 2003-10-13 | Oxis International, Inc. | Neuroprotectant methods, compositions, and screening methods thereof |
CN1805743A (zh) * | 2003-05-20 | 2006-07-19 | 特兰斯泰克制药公司 | 用作逆转淀粉样变性及其他与之相关疾病的rage拮抗剂 |
CN101468970B (zh) * | 2008-04-25 | 2011-05-11 | 暨南大学 | 一种硝酮类化合物及其制备方法和在制药中的应用 |
TWI517850B (zh) | 2009-09-30 | 2016-01-21 | Vtv治療有限責任公司 | 經取代之咪唑衍生物及其使用方法 |
JP5885620B2 (ja) * | 2012-08-22 | 2016-03-15 | 四国化成工業株式会社 | 2−(2−フリル)イミダゾール化合物及び酸化防止剤 |
FR3012458B1 (fr) | 2013-10-25 | 2015-10-30 | Michelin & Cie | Composition de caoutchouc comprenant un additif compose 1,3-dipolaire portant une fonction imidazole |
FR3012460B1 (fr) | 2013-10-25 | 2015-12-11 | Michelin & Cie | Composition de caoutchouc comprenant un elastomere dienique portant des fonctions imidazole reparties de facon aleatoire le long de la chaine |
FR3012451B1 (fr) | 2013-10-25 | 2016-11-11 | Michelin & Cie | Compose 1,3-dipolaire portant une fonction imidazole |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0643403B2 (ja) * | 1986-01-25 | 1994-06-08 | 四国化成工業株式会社 | イミダゾール―アルドキシム化合物の合成方法 |
US4803282A (en) * | 1986-08-27 | 1989-02-07 | Pennwalt Corporation | Alpha-substituted ketonitrone derivatives |
ATE209908T1 (de) * | 1991-06-18 | 2001-12-15 | Oklahoma Med Res Found | RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN |
US5455272A (en) * | 1993-10-22 | 1995-10-03 | Oklahoma Medical Research Foundation | Spin trap nitronyl hindered phenols |
CA2235765C (en) * | 1995-11-17 | 2006-04-04 | David A. Becker | Azulenyl nitrone spin trapping agents, methods of making and using same |
-
1998
- 1998-06-26 FR FR9808116A patent/FR2780404B1/fr not_active Expired - Fee Related
-
1999
- 1999-06-04 CA CA002274621A patent/CA2274621C/fr not_active Expired - Fee Related
- 1999-06-22 JP JP11175839A patent/JP2000026428A/ja active Pending
- 1999-06-23 NO NO19993122A patent/NO312722B1/no not_active IP Right Cessation
- 1999-06-24 AT AT99401565T patent/ATE223904T1/de not_active IP Right Cessation
- 1999-06-24 DK DK99401565T patent/DK0967207T3/da active
- 1999-06-24 EP EP99401565A patent/EP0967207B1/fr not_active Expired - Lifetime
- 1999-06-24 DE DE69902851T patent/DE69902851T2/de not_active Expired - Fee Related
- 1999-06-24 PT PT99401565T patent/PT967207E/pt unknown
- 1999-06-24 ES ES99401565T patent/ES2183492T3/es not_active Expired - Lifetime
- 1999-06-25 AU AU36800/99A patent/AU747203B2/en not_active Ceased
- 1999-06-25 ZA ZA9904201A patent/ZA994201B/xx unknown
- 1999-06-25 NZ NZ336460A patent/NZ336460A/xx unknown
- 1999-06-25 BR BR9903282-1A patent/BR9903282A/pt not_active IP Right Cessation
- 1999-06-25 CN CNB991112148A patent/CN1153766C/zh not_active Expired - Fee Related
- 1999-06-25 HU HU9902199A patent/HUP9902199A1/hu not_active Application Discontinuation
- 1999-06-25 US US09/340,088 patent/US6034250A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PT967207E (pt) | 2002-12-31 |
NZ336460A (en) | 2000-05-26 |
US6034250A (en) | 2000-03-07 |
DK0967207T3 (da) | 2003-01-20 |
HUP9902199A1 (hu) | 2000-06-28 |
NO312722B1 (no) | 2002-06-24 |
FR2780404B1 (fr) | 2001-04-13 |
CN1245169A (zh) | 2000-02-23 |
NO993122L (no) | 1999-12-27 |
DE69902851T2 (de) | 2003-05-28 |
JP2000026428A (ja) | 2000-01-25 |
ZA994201B (en) | 2000-01-11 |
CN1153766C (zh) | 2004-06-16 |
DE69902851D1 (de) | 2002-10-17 |
EP0967207B1 (fr) | 2002-09-11 |
AU3680099A (en) | 2000-01-13 |
CA2274621A1 (fr) | 1999-12-26 |
ATE223904T1 (de) | 2002-09-15 |
EP0967207A1 (fr) | 1999-12-29 |
HU9902199D0 (en) | 1999-08-30 |
AU747203B2 (en) | 2002-05-09 |
ES2183492T3 (es) | 2003-03-16 |
FR2780404A1 (fr) | 1999-12-31 |
NO993122D0 (no) | 1999-06-23 |
CA2274621C (fr) | 2004-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9915727A (pt) | ésteres derivados de compostos de fenil-ciclohexila substituìdos | |
BR0010716A (pt) | Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas | |
BR0214988A (pt) | S-enanciÈmero de um composto, composto, formulação farmacêutica, método de tratamento ou prevenção de distúrbios de lipìdeo, uso de um composto, método de tratamento ou prevenção de diabetes tipo 2, processo para a preparação de um composto, e, composição farmacêutica | |
BR9903282A (pt) | Compostos de nitrona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos | |
HUP0100472A2 (hu) | Új aminok, mint gyógyászati szerek | |
BRPI0015203B8 (pt) | derivado de quinazolina, composição farmacêutica, e, uso de um composto | |
KR940013508A (ko) | 우울증 및 파킨슨증후군 치료용 화합물 | |
BR0315143A (pt) | Composto, processo para a preparação dos (r) e (s) - enanciÈmeros individuais ou misturas de enanciÈmeros e sais farmaceuticamente aceitáveis de um composto, composição farmacêutica, e, uso de um composto | |
BR0210285A (pt) | Utilização de um composto, composto e composição farmacêutica | |
BRPI0407695A (pt) | compostos, processo para a preparação de um composto, composições farmacêuticas que compreendem o composto, utilização dos compostos e processo de tratamento para diabetes do tipo 2 | |
PT94167A (pt) | Processo para preparacao de novas ariloxifenilpropilaminas e de composicoes farmaceuticas que as comtem | |
FR2800735B1 (fr) | Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation | |
BR0213239A (pt) | Compostos de pirimidina com anel condensado alcinilado como inibidores da metalo-proteinase da matriz de tipo 13 | |
BR9802804A (pt) | Compostos benzimidazol, benzoxazol e benzotiazol, processo para sua preparação e composições farmacéuticas contendo os mesmos. | |
BRPI0411285A (pt) | composto, processo para preparar um composto formulação farmacêutica, uso de um composto, e, método de prevenção ou tratamento de distúrbios | |
PT96361A (pt) | Processo para a preparacao de derivados de piridazinaminas e de composicoes farmaceuticas que os contem | |
KR890011596A (ko) | 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도 | |
BR9712707A (pt) | Derivados de ácido 4-bifenil-4-hidroxibutìrico substituìdo com inibidores de metaloprotease de matriz | |
BR0104471A (pt) | Compostos de ciclobutenodiona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos | |
BR0308786A (pt) | Derivados de ftalimido como inibidores da monoamina oxidase b | |
BRPI0411729A (pt) | dicetopiperazinas substituìdas e seu uso como antagonistas da oxitocina | |
BR9903867A (pt) | Compsto de indan-1-ol, processo para seu preparo e compostos farmacêuticos contento os mesmo | |
BR0106248A (pt) | Inibidores de metaloprotease, processo para a sua preparação e composições farmacêuticas contendo os mesmos | |
BR9909870A (pt) | Pirrolidinas como inibidores de neuraminidases | |
KR900011724A (ko) | 특정 피롤릴페닐-치환된 하이드록삼산 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer |
Free format text: LES LABORATOIRES SERVIER (FR) |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1937 DE 19/02/2008 |